Beam Therapeutics Inc (BEAM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2004 | 03-2004 | 12-2003 | 09-2003 | 06-2003 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 183,400 | 152,100 | 104,600 | 161,700 | 132,300 |
| Receivables | 1,134,200 | 1,048,900 | 973,400 | 942,300 | 993,800 |
| Inventories | 985,000 | 967,700 | 956,200 | 869,000 | 869,800 |
| Other current assets | 271,800 | 276,700 | 247,400 | 281,300 | 272,100 |
| TOTAL | $2,574,400 | $2,445,400 | $2,281,600 | $2,254,300 | $2,268,000 |
| Non-Current Assets | |||||
| PPE Net | 1,330,800 | 1,347,900 | 1,358,900 | 1,191,000 | 1,184,900 |
| Investments And Advances | 0 | 0 | 74,900 | 0 | 0 |
| Intangibles | 3,360,000 | 3,345,500 | 3,328,600 | 2,400,700 | 2,386,900 |
| Other Non-Current Assets | 457,900 | 460,900 | 400,900 | 398,400 | 404,100 |
| TOTAL | $5,148,700 | $5,154,300 | $5,163,300 | $3,990,100 | $3,975,900 |
| Total Assets | $7,723,100 | $7,599,700 | $7,444,900 | $6,244,400 | $6,243,900 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 200,400 | 200,500 | 200,500 | 25,600 | 132,600 |
| Accounts payable and accrued liabilities | 357,400 | 343,900 | 316,400 | 278,500 | 279,900 |
| Accrued Expenses | 713,200 | 615,400 | 718,900 | 703,800 | 597,600 |
| Other current liabilities | N/A | N/A | 24,700 | N/A | N/A |
| TOTAL | $2,283,500 | $2,213,700 | $2,133,500 | $1,777,300 | $1,813,600 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,242,600 | 1,245,000 | 1,242,600 | 841,500 | 841,500 |
| Other Non-Current Liabilities | 1,248,000 | 1,181,400 | 843,300 | 932,900 | 948,100 |
| TOTAL | $2,650,400 | $2,592,900 | $2,591,900 | $1,954,400 | $1,976,400 |
| Total Liabilities | $4,933,900 | $4,806,600 | $4,725,400 | $3,731,700 | $3,790,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 144,036 | 146,249 | 146,280 | 145,870 | 145,241 |
| Common Shares | 717,400 | 717,400 | 717,400 | 717,400 | 717,400 |
| Retained earnings | 5,161,500 | 5,037,800 | 4,925,800 | 4,785,500 | 4,727,000 |
| Other shareholders' equity | -103,900 | -96,600 | -82,400 | -133,200 | -125,400 |
| TOTAL | $2,789,200 | $2,793,100 | $2,719,500 | $2,512,700 | $2,453,900 |
| Total Liabilities And Equity | $7,723,100 | $7,599,700 | $7,444,900 | $6,244,400 | $6,243,900 |